The world’s energy demand is rising, and NREL’s ULIS power module could help meet it. Demand for energy worldwide is climbing rapidly, driven in part by power hungry data centers that support ...
Abstract: With increasing demand for reliable and highquality power sources, utilities face significant challenges in maintaining power quality standards. Power quality issues such as voltage ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
Abstract: This study introduces a novel splitting function for the multimode dual-input power amplifier (PA) with the proposed optimization supported by a nonlinear support vector machine (SVM). The ...
'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback